A therapeutic wound gel is provided which will enhance healing of the wound
and reduce swelling and increase elasticity of the skin. Humatrix is
bacteriostatic protectant with no bacteriocidal activity. The gel consist
essentially of by weight percent, about 88-97% water, about 0.4-0.6%
carbomer, about 1.2-7.8% propylene glycol, about 0.6-1.3% glycerin, about
0.5% DMDM Hydantoin, about 0-0.8% citric acid, about 0.1% chondroitin
sulfate and animal protein, and about 0-0.6% triethanolamine. The gel is
formed in three phases which are combined together, the first phase
consisting essentially of about 88-99% of the water of the gel, the
carbomer, the propylene glycol, and the glycerin; the second phase
consisting essentially of the remaining water, the DMDM Hydantoin, and the
citric acid if needed; and the third phase consisting essentially of the
chondroitin sulfate and animal protein and the triethanolamine, if needed.
